Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Remimazolam Besylate for Sedation in Post-Non-Cardiac Surgery Patients Requiring Mechanical Ventilation: A Randomized Controlled Trial

NCT06575530 is registered in ClinicalTrials.gov with Beijing Shijitan Hospital, Capital Medical University as lead sponsor.

NCT NCT06575530
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06575530 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Remimazolam Besylate for Sedation in Post-Non-Cardiac Surgery Patients Requiring Mechanical Ventilation: A Randomized Controlled Trial
Lead sponsor
Beijing Shijitan Hospital, Capital Medical University
Phase
Phase 4
Overall status
Recruiting
Start date
January 20, 2025
Completion date
June 30, 2026
Enrollment
306 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adverse drug event, critical illness, effect of drug, mechanical ventilation complication, sedation, surgery